Locally recurrent rectal cancer: prognostic factors and long-term outcomes of multimodal therapy

Fabio Pacelli; Ap Tortorelli; Francesco Rosa; Maurizio Bossola; Am Sanchez; Valerio Papa; Viola Valentini; Gb Doglietto

doi:10.1245/s10434-009-0737-5

Locally recurrent rectal cancer: prognostic factors and long-term outcomes of multimodal therapy

Fabio Pacelli
, Ap Tortorelli
, Francesco Rosa
, Maurizio Bossola
, Am Sanchez
, Valerio Papa
, Viola Valentini
, Gb Doglietto

Research output: Contribution to journal › Article

56 Citations (Scopus)

Abstract

Pelvic recurrent rectal cancer is still a challenging clinical problem, and patients generally have a dismal prognosis and a poor quality of life. Surgical resection represents the only potentially curative treatment; neoadjuvant treatments are presently being taken into consideration to increase the resectability rate and to improve long-term survival.

Original language	English
Pages (from-to)	152-162
Number of pages	11
Journal	Annals of Surgical Oncology
Volume	17
DOIs	https://doi.org/10.1245/s10434-009-0737-5
Publication status	Published - 2010

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols
Combined Modality Therapy
Female
Fluorouracil
Follow-Up Studies
Humans
Leucovorin
Male
Middle Aged
Neoplasm Recurrence, Local
Neoplasm Staging
Pelvic Neoplasms
Prognosis
Rectal Neoplasms
Retrospective Studies
Surgical Procedures, Operative
Survival Rate

Access to Document

10.1245/s10434-009-0737-5

Cite this

@article{0b9fe242de464c5e9ff47fe977813285,

title = "Locally recurrent rectal cancer: prognostic factors and long-term outcomes of multimodal therapy",

abstract = "Pelvic recurrent rectal cancer is still a challenging clinical problem, and patients generally have a dismal prognosis and a poor quality of life. Surgical resection represents the only potentially curative treatment; neoadjuvant treatments are presently being taken into consideration to increase the resectability rate and to improve long-term survival.",

keywords = "Adult, Aged, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols, Combined Modality Therapy, Female, Fluorouracil, Follow-Up Studies, Humans, Leucovorin, Male, Middle Aged, Neoplasm Recurrence, Local, Neoplasm Staging, Pelvic Neoplasms, Prognosis, Rectal Neoplasms, Retrospective Studies, Surgical Procedures, Operative, Survival Rate, Adult, Aged, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols, Combined Modality Therapy, Female, Fluorouracil, Follow-Up Studies, Humans, Leucovorin, Male, Middle Aged, Neoplasm Recurrence, Local, Neoplasm Staging, Pelvic Neoplasms, Prognosis, Rectal Neoplasms, Retrospective Studies, Surgical Procedures, Operative, Survival Rate",

author = "Fabio Pacelli and Ap Tortorelli and Francesco Rosa and Maurizio Bossola and Am Sanchez and Valerio Papa and Viola Valentini and Gb Doglietto",

year = "2010",

doi = "10.1245/s10434-009-0737-5",

language = "English",

volume = "17",

pages = "152--162",

journal = "Annals of Surgical Oncology",

issn = "1534-4681",

publisher = "Springer Science and Business Media Deutschland GmbH",

}

TY - JOUR

T1 - Locally recurrent rectal cancer: prognostic factors and long-term outcomes of multimodal therapy

AU - Pacelli, Fabio

AU - Tortorelli, Ap

AU - Rosa, Francesco

AU - Bossola, Maurizio

AU - Sanchez, Am

AU - Papa, Valerio

AU - Valentini, Viola

AU - Doglietto, Gb

PY - 2010

Y1 - 2010

N2 - Pelvic recurrent rectal cancer is still a challenging clinical problem, and patients generally have a dismal prognosis and a poor quality of life. Surgical resection represents the only potentially curative treatment; neoadjuvant treatments are presently being taken into consideration to increase the resectability rate and to improve long-term survival.

AB - Pelvic recurrent rectal cancer is still a challenging clinical problem, and patients generally have a dismal prognosis and a poor quality of life. Surgical resection represents the only potentially curative treatment; neoadjuvant treatments are presently being taken into consideration to increase the resectability rate and to improve long-term survival.

KW - Adult

KW - Aged

KW - Aged, 80 and over

KW - Antineoplastic Combined Chemotherapy Protocols

KW - Combined Modality Therapy

KW - Female

KW - Fluorouracil

KW - Follow-Up Studies

KW - Humans

KW - Leucovorin

KW - Male

KW - Middle Aged

KW - Neoplasm Recurrence, Local

KW - Neoplasm Staging

KW - Pelvic Neoplasms

KW - Prognosis

KW - Rectal Neoplasms

KW - Retrospective Studies

KW - Surgical Procedures, Operative

KW - Survival Rate

KW - Adult

KW - Aged

KW - Aged, 80 and over

KW - Antineoplastic Combined Chemotherapy Protocols

KW - Combined Modality Therapy

KW - Female

KW - Fluorouracil

KW - Follow-Up Studies

KW - Humans

KW - Leucovorin

KW - Male

KW - Middle Aged

KW - Neoplasm Recurrence, Local

KW - Neoplasm Staging

KW - Pelvic Neoplasms

KW - Prognosis

KW - Rectal Neoplasms

KW - Retrospective Studies

KW - Surgical Procedures, Operative

KW - Survival Rate

UR - http://hdl.handle.net/10807/33112

U2 - 10.1245/s10434-009-0737-5

DO - 10.1245/s10434-009-0737-5

M3 - Article

SN - 1534-4681

VL - 17

SP - 152

EP - 162

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

ER -

Locally recurrent rectal cancer: prognostic factors and long-term outcomes of multimodal therapy

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this